Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 101501 - 101520 out of 563789 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 20 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 20 MG/ML SOL DIL INFUS IV CT 4 FA VD TRANS X 4 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 20 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 20 MG/ML SOL DIL INFUS IV CT 4 FA VD TRANS X 10 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 20 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 20 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 20 MG/ML SOL DIL INFUS IV CT 4 FA VD TRANS X 20 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | ACTEMRA | 20 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 20 ML | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | PRODUTOSROCHEQUÍMICOSEFARMACÊUTICOSS.A. |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | ACTEMRA | 20 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | PRODUTOSROCHEQUÍMICOSEFARMACÊUTICOSS.A. |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | ACTEMRA | 20 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | PRODUTOSROCHEQUÍMICOSEFARMACÊUTICOSS.A. |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | ACTEMRA | 162 MG SOL INJ SC CT 4 SER PREENC VD TRANS X 0,9 ML | Wholesale price without vat |
$0-0 |
$0-0 |
n/a | PRODUTOSROCHEQUÍMICOSEFARMACÊUTICOSS.A. |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | AVTOZMA | 162 MG SOL INJ CT 1 SER PREENC VD TRANS X 0,9 ML + PROT ESP AGU | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CELLTRIONHEALTHCAREDISTRIBUICAODEPRODUTOSFARMACEUTICOSDOSBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | AVTOZMA | 162 MG SOL INJ CT 4 SER PREENC VD TRANS X 0,9 ML + PROT ESP AGU | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CELLTRIONHEALTHCAREDISTRIBUICAODEPRODUTOSFARMACEUTICOSDOSBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | AVTOZMA | 162 MG SOL INJ CT 1 SER PREENC VD TRANS X 0,9 ML + CAN APLIC | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CELLTRIONHEALTHCAREDISTRIBUICAODEPRODUTOSFARMACEUTICOSDOSBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | AVTOZMA | 162 MG SOL INJ CT 4 SER PREENC VD TRANS X 0,9 ML + CAN APLIC | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CELLTRIONHEALTHCAREDISTRIBUICAODEPRODUTOSFARMACEUTICOSDOSBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 162 MG SOL INJ SC CT 1 SER PREENC VD TRANS X 0,9 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 162 MG SOL INJ SC CT 4 SER PREENC VD TRANS X 0,9 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 162 MG SOL INJ SC CT 12 SER PREENC VD TRANS X 0,9 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 162 MG SOL INJ SC CT 1 CAN APLIC X 0,9 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 162 MG SOL INJ SC CT 4 CAN APLIC X 0,9 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
| Brasil (GOV) | (L04AC07) tocilizumab (adm: P) | TYENNE | 162 MG SOL INJ SC CT 12 CAN APLIC X 0,9 ML | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FRESENIUSKABIBRASILLTDA |
